This test is most useful if any of these apply to you.
If you have reacted to shrimp but standard testing only points to the main shrimp allergen, you may be missing part of the picture. A small but real subset of shrimp-allergic people are sensitized to a different muscle protein, and they can be missed entirely by tropomyosin-only testing.
This test looks at a specific shrimp molecule called Pen m 2 (arginine kinase) from black tiger shrimp (Penaeus monodon), the source species used for the Pen m allergen nomenclature, though commercial shrimp tests can use other shrimp species too. Knowing whether your immune system reacts to this specific protein helps clarify your allergy profile when broader tests are ambiguous.
Pen m 2 is one of several recognized shrimp allergens used in component-resolved diagnosis, which is a way of testing your reaction to individual shrimp proteins rather than to a whole shrimp extract. Arginine kinase is a muscle protein found in shrimp and other crustaceans, and your body can make antibodies (called IgE, the antibody type behind allergies) that recognize it. Notably, arginine kinase sensitization has been found in people with dust mite or cockroach allergy who are not actually shrimp-allergic, which means a positive Pen m 2 may specifically mark cross-reactivity rather than confirming shrimp allergy.
In European shrimp-allergic cohorts, Pen m 2 is considered a minor allergen relative to the main shrimp protein called tropomyosin (Pen m 1). In a Central European study of 79 shrimp-allergic patients, about 20% had detectable Pen m 2 antibodies, but only a small fraction were sensitized to Pen m 2 alone. A larger Central European cohort of 108 patients using a different multiplex assay found around 14% sensitization to Pen m 2, usually at low antibody levels and rarely as the sole sensitizing molecule. The clinical relevance of individual shrimp components is also population-dependent: in a Hong Kong cohort, Pen m 6 and Pen m 14 were actually the most common shrimp allergens, a very different hierarchy from European populations.
Different shrimp proteins are linked to different patterns of reaction. Tropomyosin sensitization is the allergen most often tied to systemic reactions (involving more than just one body part). Pen m 2 and another minor shrimp molecule called Pen m 4 (a calcium-binding protein) are not strongly linked to severe reactions in European cohort data, though direct evidence connecting Pen m 2 to milder phenotypes is limited. It is better thought of as an absence of a clear severity signal rather than a positive marker of mild disease.
In an Italian multicenter study of 247 shrimp-allergic patients, severe reactions to mollusks (such as oysters, clams, and squid) were linked to the main tropomyosin allergen, not to Pen m 2. Some reports suggest that, in the subgroup who underwent detailed molecular testing, those who also reacted to mollusks showed a higher frequency of Pen m 2 antibodies, but this specific subgroup finding has not been independently confirmed. The dominant signal in the literature is that tropomyosin drives severe crustacean and mollusk reactions.
Shrimp and house dust mites share several similar proteins, which is why dust mite-allergic people sometimes test positive for shrimp proteins even if they tolerate shrimp without issue. The most established cross-reactive molecule between shrimp and mites is tropomyosin (Pen m 1 and the mite equivalent Der p 10). Arginine kinase is also a recognized cross-reactive family: a dust mite arginine kinase called Der p 20 exists and shares structure with Pen m 2, though the direct evidence base for a strong Pen m 2 to Der p 20 antibody correlation is thinner than for the tropomyosin pairing. The practical point is the same: a positive Pen m 2 result does not always mean shrimp itself is the problem.
In Algerian patients with house dust mite allergy, screening for shrimp sensitization revealed a strong link between dust mite reactivity and detectable shrimp antibodies, even in people who had never knowingly reacted to shrimp. A Swedish population study of 4,593 people reported that around 5% were sensitized to shrimp and around 4% to dust mites, with substantial overlap between the two.
A positive Pen m 2 antibody result does not automatically equal a clinically meaningful shrimp allergy, and a negative result does not rule one out. This molecule sits inside a panel of shrimp proteins, and the dominant ones vary by population: in most European cohorts the leaders are Pen m 1 (tropomyosin) and Pen m 4, while Pen m 6 and Pen m 14 dominate in some Asian cohorts. Pen m 2 is best understood as part of a broader sensitization fingerprint that, combined with your clinical history, helps an allergist phenotype your reactivity.
Shrimp extract antibody tests are sensitive (they pick up most shrimp-allergic people) but not very specific (they often flag people who actually tolerate shrimp, particularly dust mite-allergic individuals). Component tests like Pen m 2 add detail: they can identify the small fraction of patients sensitized only to a minor molecule, who would be missed by tropomyosin-only testing.
In one Central European cohort, the combined panel of recombinant shrimp components (Pen m 1, Pen m 2, Pen m 3, Pen m 4, and a related crab molecule) reached an overall sensitivity of around 68%. No single component, including Pen m 2, was sufficient on its own. A meta-analysis of shrimp allergy diagnostic tests reported pooled accuracy figures only for tropomyosin, with no equivalent pooled figures for Pen m 2.
Allergic sensitization is a moving target. Antibody levels can change over months and years, and a single result captures only one moment. In a Thai pediatric study of shrimp-allergic children followed over time, antibody levels and the ratio of protective antibodies to allergic antibodies were able to predict who would naturally outgrow shrimp allergy versus who would not. A separate study found that children had more intense antibody binding to shrimp proteins than adults, suggesting sensitization can fade over decades.
If you are tracking your shrimp allergy or trying to understand whether your sensitization is changing, get a baseline measurement, then consider repeat testing every 12 to 24 months, or sooner if you complete a supervised challenge or therapeutic intervention. This interval reflects expert practice rather than a guideline-mandated schedule. A single Pen m 2 number in isolation cannot answer whether your allergy is improving or worsening.
If your Pen m 2 result is elevated and you have a history of reacting to shrimp, the next step is rarely to retest the same marker in isolation. The decision pathway typically involves testing the full set of shrimp components (Pen m 1, Pen m 3, Pen m 4, Pen m 6, and where available Pen m 14), along with house dust mite components (especially Der p 1, Der p 2, Der p 10, and Der p 23, with Der p 20 added when arginine kinase cross-reactivity is in question) to clarify whether your sensitization is genuine shrimp allergy or cross-reactivity from dust mite exposure.
If you have never knowingly reacted to shrimp but Pen m 2 is positive, the workup focuses on whether you can safely continue eating shrimp. Many people with positive component results have no clinical reaction. A supervised oral food challenge with an allergist is the most reliable way to confirm or rule out actual allergy. Avoiding shrimp on the basis of a single positive antibody result alone, without clinical history, is generally not recommended.
A few situations can make a single antibody reading harder to interpret:
Black Tiger Shrimp (Pen m 2) IgE is best interpreted alongside these tests.
Black Tiger Shrimp (Pen m 2) IgE is included in these pre-built panels.